Skip to main content
Clinical Trials/NCT02388607
NCT02388607
Unknown
Not Applicable

Sustained Attention Abilities, Attentional Resources and Cognitive Control Mechanisms in Schizophrenia

University Hospital, Strasbourg, France1 site in 1 country80 target enrollmentMarch 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Schizophrenic Psychoses
Sponsor
University Hospital, Strasbourg, France
Enrollment
80
Locations
1
Primary Endpoint
Assess sustained attention span of patients with schizophrenia
Last Updated
4 years ago

Overview

Brief Summary

Schizophrenia is a psychiatric pathology, which concerns around 1% of adult population. It is characterized by clinical symptoms combining positive and negative symptoms and thinking disorganization. Schizophrenia is also characterized by cognitive deficits, likely to play an important part in adaptation of these patients in their every-day life, and to affect their clinical symptomatology. Among them, there are deficits in sustained attention which are associated with a difficulty for these patients to maintain efficiently their cognitive activity on a source of stimulation or task. This basic attentional process is fundamental for the efficiency of the overall of cognitive processes, and so for all behaviors directed on an aim. The question of whether or not patients with schizophrenia have difficulty sustaining attention is of high relevance, in the sense that it could undermine performance on nearly any task and so provide a compelling causal explanation of many other impairments observed in these patients. Yet it has not been conclusively answered in over four decades of research. Consequently, the main objective of the protocol is to evaluate sustained attention abilities in schizophrenic patients and to better understand the specific functioning of cognitive and neural mechanisms underlying these abilities (attentional resources and cognitive control mechanisms).

Registry
clinicaltrials.gov
Start Date
March 2015
End Date
March 2023
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Strasbourg, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • age between 18 and 60 years (include)
  • men or women volunteers, hospitalized or not
  • subject affiliated to an health insurance
  • subject having signed an informed consent (for patients):
  • presence of DSM-IV TR criteria for schizophrenia (American Psychiatric Association, 1994)
  • Exclusion criteria
  • a major somatic disorder or non stabilized
  • medical history likely to affect cerebral anatomy or to be linked to an abnormality (neonatal distress, neurochirurgical intervention, neurological disorders, stroke attack)
  • any disorders involved in the use of a psycho-active substance (as defined by the DSM-IV)
  • sensory disabling impairments, and specifically visual acuity \< 8

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Assess sustained attention span of patients with schizophrenia

Time Frame: two half-days

Subjects are involved in 4 different attentional tasks during which behavioral and electrophysiological measures are recorded in order to evaluate sustained attention abilities and the specific functioning of cognitive and neural mechanisms underlying these abilities in schizophrenic patients.

Secondary Outcomes

  • Study the specific mechanisms underlying attention skills supported in schizophrenic patients(two half-days)

Study Sites (1)

Loading locations...

Similar Trials